Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Cryotherapy for the prevention of weekly paclitaxel-induced peripheral adverse events in breast cancer patients
Insulin resistance: The degree of insulin resistance may affect how the body responds to the GIP and GLP-1 components of the drug, though again this is extrapolated from class data rather than retatrutide-specific evidence
Side Effects: There were no serious incidents of hypoglycaemia (too little blood sugar) reported, nor were there any maglinancies in the thyroid gland or reports persistent hyperglycaemia (too much blood sugar) 8% of patients across all Retatrutide groups collectively did not continue treatment because of an adverse event The most commonly reported adverse events in people taking Retatrutide were gastrointestinal in nature (constipation, diarrhea, vomiting, nasuea), were mild to moderate in severity, and happened more often in people taking larger doses of Retatrutide All in all, patients on Retatrutide experienced a dramatic improvement in insulin sensitivity and any observed side effects were not significantly different in severity, type or frequency compared to the Phase 2 trial for obesity
Kaku K, Katou M, Igeta M, Ohira T, Sano H
G.WenJ.ZhangX
